ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "Building Successful Market Access Strategies from Day One - BioPharma Unscripted Ep. 6"
Episode Synopsis
Building Successful Market Access Strategies from Day One - BioPharma Unscripted Ep. 6In this episode of BioPharma Unscripted!, host Marcus speaks with pharmaceutical market access expert Ana Filipa Alexandre, PharmD, MPH about the critical importance of early access planning in drug development.Ana shares insights from her extensive career spanning regulatory affairs, health economics, and market access, explaining why companies must consider access strategies from the earliest stages of development. In This Episode You'll LearnWhat market access truly encompasses beyond regulatory approvalWhy companies frequently fail to start market access planning early enoughHow to build a compelling "value story" with evidence-based value propositionsThe specific consequences when market access planning is inadequateSpecial considerations for small biotech companies with limited resourcesThe critical relationship between health economics and market access functionsWhy post-launch market access activities remain important throughout a product's lifecycleHow the upcoming Joint Clinical Assessment (JCA) might impact European market accessWhether you're a pharmaceutical professional, biotech entrepreneur or healthcare policy expert, this episode offers valuable insights into how successful drugs make the journey from lab to patient.Ana Filipa Alexandre, PharmD, MPH: Ana is a pharmacist by training with extensive experience in market access across affiliate and global roles. Connect with Ana on LinkedIn: https://www.linkedin.com/in/ana-filipa-alexandre-pharmd-mph/Chapters 00:00 Introduction and Ana's background 01:31 Ana's journey into pharmaceutical market access 02:25 Defining market access as a process 04:44 Why companies fail to start market access planning early 07:06 Cross-functional collaboration in market access 08:26 Building the value story for new products 11:04 Challenges for small biotech companies 13:24 Example of effective early access planning 16:38 Advice for early-stage biotechs on market access 19:40 The role of consultants vs in-house expertise 21:42 Consequences of inadequate market access planning 24:16 Career development in market access27:11 Post-launch considerations in market access 29:19 Concluding remarks Connect with Marcus: https://www.linkedin.com/in/marcus-metcalfe-8938a35/ Marcus helps US & European Biotech & Pharmaceutical clients by providing Interim/Fractional & Advisory consultants for operational & strategic needs.I also work on selective Executive Search (perm) projects.I have helped Clients when there is no headcount, when they can't find the right permanent candidate, when they have a spike in business, as an alternative to an external vendor or for those simply needing an extra pair of hands.If you need a partner with an extensive network in HEOR and Market Access - this is his sweet spot.He has placed over 120 HEOR and Market Access candidates during my time across US and Europe.With his business partners, he covers the below functional areas.• Biometrics • Business Development• Clinical Research • Drug safety & Product safety• Engineering • Health Economics• Medical Affairs • Market Access• Regulatory Affairs • Compliance/Quality Assurance• Marketing & Medical • Scientific & Preclinical• CommunicationsPodcast produced by www.podforge.co.uk
In God we trust